Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects (2008)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SILVA JUNIOR, WILSON ARAÚJO DA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1515/cclm.2008.014
- Subjects: POLIMORFISMO; METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Chemistry and Laboratory Medicine
- ISSN: 1434-6621
- Volume/Número/Paginação/Ano: v. 46, n. 1, p. 57-63, 2008
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DEMACQ, Caroline et al. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, v. 46, n. 1, p. 57-63, 2008Tradução . . Disponível em: https://doi.org/10.1515/cclm.2008.014. Acesso em: 15 fev. 2026. -
APA
Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Silva Júnior, W. A. da, & Tanus-Santos, J. E. (2008). Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, 46( 1), 57-63. doi:10.1515/cclm.2008.014 -
NLM
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2026 fev. 15 ] Available from: https://doi.org/10.1515/cclm.2008.014 -
Vancouver
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2026 fev. 15 ] Available from: https://doi.org/10.1515/cclm.2008.014 - Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
Informações sobre o DOI: 10.1515/cclm.2008.014 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
